Patents by Inventor Tricia J. Vos

Tricia J. Vos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Certain pyrazoline derivatives with kinase inhibitory activity
    Publication number: 20080171754
    Abstract: The present invention provides certain pyrazoline compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutical compositions and methods of using the compositions in the treatment of various diseases.
    Type: Application
    Filed: December 19, 2007
    Publication date: July 17, 2008
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Ruth S. Adams, Matthew Duffey, Alexandra E. Gould, Paul D. Greenspan, Bheemashankar A. Kulkarni, Tricia J. Vos
  • Melanocortin-4 receptor binding compounds and methods of use thereof
    Patent number: 7375125
    Abstract: Provided are MC4-R binding compounds of the formula XVII: wherein L2 is a linker group, and P1, P2, P3, P4, Z1, Z2, Z3, Z4, Z5, t, s, and R are as described in the specification. Methods of using the compounds to treat MC4-R associated disorders, such as disorders associated with weight loss, are also provided.
    Type: Grant
    Filed: June 16, 2003
    Date of Patent: May 20, 2008
    Assignee: Ore Pharmaceuticals, Inc.
    Inventors: Tricia J. Vos, Michael E. Solomon, Christopher F. Claiborne, Martin P. Maguire, Mingshi Dai, Michael Patane, Thomas H. Marsilje
  • Modulators of melanocortin receptor
    Patent number: 7365070
    Abstract: This invention provides compounds and methods for treating melanocortin receptor associated disorders, such as weight loss disorders including cachexia resulting from cancer and other chronic illnesses. The compounds are represented by formula I: wherein X is oxygen or sulfur; G is G1 or G2: L1, L2, L3 and Q are linker groups, and Rings A, B and C, and R1-R14 are described in the specification. The compounds are antagonists of melanocortin receptors.
    Type: Grant
    Filed: December 4, 2003
    Date of Patent: April 29, 2008
    Assignee: Ore Pharmaceuticals Inc.
    Inventors: Tricia J. Vos, Michael Patane, Michael E. Solomon, Christopher Blackburn, Mihaela D. Danca
  • Modulators of melanocortin receptor
    Publication number: 20040147746
    Abstract: This invention provides compounds and methods for treating melanocortin receptor associated disorders, such as weight loss disorders including cachexia resulting from cancer and other chronic illnesses.
    Type: Application
    Filed: December 4, 2003
    Publication date: July 29, 2004
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Tricia J. Vos, Michael Patane, Michael E. Solomon, Christopher Blackburn, Mihaela D. Danca
  • Melanocortin-4 receptor binding compounds and methods of use thereof
    Publication number: 20040082779
    Abstract: Provided are MC4-R binding compounds of the formula XVII: 1
    Type: Application
    Filed: June 16, 2003
    Publication date: April 29, 2004
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Tricia J. Vos, Michael E. Solomon, Christopher F. Claiborne, Martin P. Maguire, Mingshi Dai, Michael Patane, Thomas H. Marsilje
  • Melanocortin-4 receptor binding compounds and methods of use thereof
    Patent number: 6699873
    Abstract: MC4-R binding compounds of the formula: B—Z—E  (I) wherein B is an anchor moiety, Z is a central moiety, and E is a MC4-R interacting. moiety are discussed. Methods of using the compounds to treat MC4-R associated disorders, such as disorders associated with weight loss, are also discussed.
    Type: Grant
    Filed: February 7, 2001
    Date of Patent: March 2, 2004
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Martin P. Maguire, Mingshi Dai, Tricia J. Vos